Patents by Inventor Simon Popp

Simon Popp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240368266
    Abstract: The present invention relates to antibodies binding to human interleukin-2 (hIL-2). The invention more specifically relates to humanized antibodies specifically binding a particular epitope of hIL-2 and, when bound to this epitope, displaying a unique capability of inhibiting binding of hIL-2 to CD25.
    Type: Application
    Filed: November 14, 2023
    Publication date: November 7, 2024
    Applicant: Universität Zürich
    Inventors: Natalia Arenas-Ramirez, Iwan Beuvink, Onur Boyman, Barbara Brannetti, Andreas Katopodis, Simone Popp, Catherine Regnier, Chao Zou
  • Patent number: 11851484
    Abstract: The present invention relates to antibodies binding to human interleukin-2 (hIL-2). The invention more specifically relates to humanized antibodies specifically binding a particular epitope of hIL-2 and, when bound to this epitope, displaying a unique capability of inhibiting binding of hIL-2 to CD25.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: December 26, 2023
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Natalia Arenas-Ramirez, Iwan Beuvink, Onur Boyman, Barbara Brannetti, Andreas Katopodis, Simone Popp, Catherine Regnier, Chao Zou
  • Patent number: 11493907
    Abstract: A data acquisition system for dielectric analysis measurements, including a sensor interface configured to connect to one or more sensors located within an active machining zone of an industrial manufacturing machine, a module processor coupled to the sensor interface and configured to receive measurement values from one or more sensors connected to the sensor interface, a cloud interface coupled to the module processor, and a machine interface coupled to the module processor. The measurement values indicate physical properties of workpieces processed in the active machining zone of an industrial manufacturing machine. The cloud interface is configured to connect to cloud-based resources, and the machine interface is configured to connect to a controller of the industrial manufacturing machine.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: November 8, 2022
    Assignee: NETZSCH Process Intelligence GmbH
    Inventors: Alexander Chaloupka, Marco Zier, Bernd Bohanka, Elena Moukhina, Thilo Hilpert, Simon Popp
  • Publication number: 20210246200
    Abstract: The present invention relates to antibodies binding to human interleukin-2 (hIL-2). The invention more specifically relates to humanized antibodies specifically binding a particular epitope of hIL-2 and, when bound to this epitope, displaying a unique capability of inhibiting binding of hIL-2 to CD25.
    Type: Application
    Filed: December 17, 2020
    Publication date: August 12, 2021
    Applicants: Universität Zürich
    Inventors: Natalia Arenas-Ramirez, Iwan Beuvink, Onur Boyman, Barbara Brannetti, Andreas Katopodis, Simone Popp, Catherine Regnier, Chao Zou
  • Publication number: 20210041857
    Abstract: A data acquisition system for dielectric analysis measurements, including a sensor interface configured to connect to one or more sensors located within an active machining zone of an industrial manufacturing machine, a module processor coupled to the sensor interface and configured to receive measurement values from one or more sensors connected to the sensor interface, a cloud interface coupled to the module processor, and a machine interface coupled to the module processor. The measurement values indicate physical properties of workpieces processed in the active machining zone of an industrial manufacturing machine. The cloud interface is configured to connect to cloud-based resources, and the machine interface is configured to connect to a controller of the industrial manufacturing machine.
    Type: Application
    Filed: May 29, 2020
    Publication date: February 11, 2021
    Inventors: Alexander Chaloupka, Marco Zier, Bernd Bohanka, Elena Moukhina, Thilo Hilpert, Simon Popp
  • Patent number: 10889643
    Abstract: The present invention relates to antibodies binding to human interleukin-2 (hIL-2). The invention more specifically relates to humanized antibodies specifically binding a particular epitope of hIL-2 and, when bound to this epitope, displaying a unique capability of inhibiting binding of hIL-2 to CD25.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: January 12, 2021
    Assignee: Universität Zürich
    Inventors: Natalia Arenas-Ramirez, Iwan Beuvink, Onur Boyman, Barbara Brannetti, Andreas Katopodis, Simone Popp, Catherine Regnier, Chao Zou
  • Publication number: 20190016797
    Abstract: The present invention relates to antibodies binding to human interleukin-2 (hIL-2). The invention more specifically relates to humanized antibodies specifically binding a particular epitope of hIL-2 and, when bound to this epitope, displaying a unique capability of inhibiting binding of hIL-2 to CD25.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 17, 2019
    Applicants: Novartis AG, Universität Zürich
    Inventors: Natalia Arenas-Ramirez, Iwan Beuvink, Onur Boyman, Barbara Brannetti, Andreas Katopodis, Simone Popp, Catherine Regnier, Chao Zou